Apnimed, Inc.

Apnimed is a pharmaceutical company developing a pill to treat obstructive sleep apnea, a condition where people's breathing stops and starts during sleep. The main drug candidate is called AD109, which works by addressing the muscle control problems in the throat that cause the condition. The company was founded in 2017 and is based in Cambridge, Massachusetts.